Renasant Bio has raised $54.5 million in seed funding led by 5AM Ventures to develop disease-modifying treatments for ADPKD. The funding will support the progression of their lead programs targeting this genetic disorder.
Amount Raised
$54.5 Million
Round Type
Seed
BerkeleyBiotechnologyHealth CareTherapeuticsInvestors
Description
Renasant Bio has launched to advance treatments for autosomal dominant polycystic kidney disease (ADPKD). They have raised $54.5 million in seed funding, co-led by 5AM Ventures. The funding will support the company's pipeline of oral small molecule therapies. Renasant aims to address the underlying biology of ADPKD and halt disease progression.
Quick answer
Renasant Bio raised $54.5 Million in a Seed round, dated July 10, 2025. Investors: Orbimed, 5AM Ventures, Atlas Venture and Qiming Venture Partners USA. Renasant Bio is based in Berkeley, California, United States.
- How much did Renasant Bio raise?
- Renasant Bio raised $54.5 Million in a Seed round on July 10, 2025.
- Who invested in Renasant Bio?
- Orbimed, 5AM Ventures, Atlas Venture and Qiming Venture Partners USA are named as investors in this round.
- What does Renasant Bio do?
- Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments for autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of end-stage renal failure.
- Where is Renasant Bio based and how big is it?
- Renasant Bio is based in Berkeley, California, United States. Fundz records about 15 employees.
- Who are the decision-makers at Renasant Bio?
- Fundz holds 1 contact at Renasant Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Renasant Bio that raised within 45 days of this round, from Fundz verified event records.
- QurAlis raised $20M on August 21, 2025.
- Calidi Biotherapeutics raised $6.9M (Post-IPO Equity) on August 21, 2025.
- CILA Therapeutics raised an undisclosed amount (Grant) on August 15, 2025.
- Eyestem raised $10M (Series B) on August 11, 2025.
- Tevogen Inc. raised $1M (Funding Round) on August 7, 2025.
- Retension Pharmaceuticals raised $15M (Series B) on August 6, 2025.
Who to call at Renasant Bio, and when
A new round usually means Renasant Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Renasant Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Renasant Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Renasant Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Renasant Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Renasant Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.